Agoracom: Small Cap Investment - Zenith Epigenetics - Should we expect a synopsis from yesterday’s AGM?

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

jbuffett62

Rank: Treasurer [?]

Points: 480 [?]

Votes: 13 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Should we expect a synopsis from yesterday’s AGM?

posted on Oct 28, 2022 06:13AM

Nothing here, nothing on Twitter.

3 Recommendations

Re: Should we expect a synopsis from yesterday’s AGM?

KOO-KOO2

Oct 28, 2022 09:12AM

Re: Should we expect a synopsis from yesterday’s AGM?

fuzzyjr

Oct 28, 2022 01:11PM

Reply New Message

Back To Forum List View

Please to post a reply